Sanofi is a French multinational healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication.
In October 2009, Sanofi-Aventis bought a 74 percent stake in insulin manufacturer Bioton Vostok. This enterprise, located in Orel, was named Sanofi-Aventis Vostok and specializes in the production of insulins.
The company promised to stop any new spending not related to the supply of the essential and life-changing medicines and vaccines in Russia, as well as in Belarus. Increased revenue, profit and assets in Russia in 2022 vs 2021. Customs data shows that the latest deliveries were in 2023. Sanofi experiencing serious supply problems from its Russian plant to EU market.